The United States food and drug administration approved bayer carcinoma pill treatment of cancer of the intestines, don't deal with any other treatment method to expand on Monday.
This drug is called Stivarga and regulators approved it to treat gastrointestinal stromal tumor can't surgery, no longer response other FDA approved drugs.
Previously, Stivarga approved by FDA to chemotherapy for colorectal cancer. It works by blocking the various enzymes, promote the growth of cancer cells.
The United States food and drug administration approved drugs for nearly 200 patients were randomly assigned to take Stivarga or placebo research based on the new use.
, in all patients taking the drug cancer compared with placebo, an increase of nearly 4 months of delay.
In the clinical trials Stivarga serious side effects, including liver damage, severe bleeding, foaming, peeling, high blood pressure, heart attacks and perforation.
Approved for the treatment of intestinal cancer drugs, including gleevec, novartis, and Sutent by Pfizer
Bayer medical care co., LTD. Is the German bayer company a subsidiary company
 



Other News:
FDA expands approval of Bayer cancer drug
CEO Paul McIlhenny at co.that makes Tabasco dies
Damage causes and protect measures of bearings
Obama urges Congress to 'compromise' on cuts
Missouri Powerball winners live modestly, give back to hometown
2013 Gold Cup to kick off with Mexico at the Rose Bowl
Italy faces political gridlock after crucial elex
Italy vote may bring opposite of what country needs